Canada ranks 16th out of 18 industrialized countries with national health systems in accessing new medicines through publicly-funded drug plans, says a pharmaceutical industry report. The research prompted renewed calls in Parliament for an all-Canadian pharmacare program: “The whole idea is to come together”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
